SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-065440
Filing Date
2020-05-22
Accepted
2020-05-22 17:05:57
Documents
16
Period of Report
2020-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020220-1_8k.htm   iXBRL 8-K 76153
2 EXHIBIT 2.1 tm2020220d1_ex2-1.htm EX-2.1 46441
3 EXHIBIT 2.2 tm2020220d1_ex2-2.htm EX-2.2 31847
4 EXHIBIT 3.1 tm2020220d1_ex3-1.htm EX-3.1 112076
8 GRAPHIC tm2020220d1_ex2-2img01.jpg GRAPHIC 12431
  Complete submission text file 0001104659-20-065440.txt   511701

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA asrt-20200519.xsd EX-101.SCH 3192
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20200519_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20200519_pre.xml EX-101.PRE 22714
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2020220-1_8k_htm.xml XML 3723
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13111 | Film No.: 20906870
SIC: 2834 Pharmaceutical Preparations